Gala Pharmaceutical, Inc. Reports Earnings Results for the Full Year Ended November 30, 2018
April 15, 2019 at 09:49 pm
Gala Pharmaceutical, Inc. announced earnings results for the full year ended November 30, 2018. For the full year, the company announced sales was USD 4,675 compared to USD 0 a year ago. Net loss was USD 1.858 million compared to USD 1.981 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.09 a year ago.